In recent years RDD has been recategorized as a neoplastic disease, one-third of patients have been identified with mutually exclusive Kirsten Rat Sarcoma viral oncogene homolog (KRAS) and MAP2K1 mutations [45]. This evidence concerns the gene KRAS and neoplasm.